Renal dynamic contrast-enhanced MRI scan data from five healthy control participants and one patient with moderate renal impairment, acquired on a Philips Achieva 3T MRI scanner at Newcastle University.
The contrast agent used was Gd-DOTA (Dotarem, Guerbet, France) at 0.05mmol/kg body weight (ie. half the standard Dotarem dose).